I42.2
Other hypertrophic cardiomyopathy
Clinical Classification Guidelines
Inclusion Terms
- Nonobstructive hypertrophic cardiomyopathy
Medical Intelligence & Overview
Other hypertrophic cardiomyopathy (ICD-10 code I42.2) is a condition where the heart muscle, particularly the walls of the heart's ventricles, becomes abnormally thickened without causing an obstruction to blood flow. This form of hypertrophic cardiomyopathy is classified as nonobstructive, meaning it does not block blood flow out of the heart, which can influence how the condition affects patients and how it is managed.
Causes & Symptoms
Clinical Causes: Genetic factors: inherited gene mutations affecting heart muscle proteins. Family history of hypertrophic cardiomyopathy or other cardiomyopathies. Certain metabolic or connective tissue diseases that may impact heart structure. Environmental factors that might contribute to abnormal heart muscle growth, though less common.
Key Symptoms: Shortness of breath, especially during physical activity or exertion. Chest pain or discomfort, sometimes mistaken for angina. Palpitations or irregular heartbeat sensations. Fatigue or decreased exercise capacity. Dizziness or fainting episodes, particularly during exertion. In some cases, the condition may be asymptomatic and discovered incidentally during medical evaluations.
Diagnostic & Treatment
Diagnosis Path: Diagnosing other hypertrophic cardiomyopathy involves a combination of medical history, physical examination, and specialized tests. Common diagnostic procedures include: - Echocardiogram (ultrasound of the heart): Provides images of heart muscle thickness and function. - Electrocardiogram (ECG): Records the electrical activity of the heart to identify abnormal rhythms or patterns. - Cardiac MRI: Offers detailed images for precise assessment of heart muscle hypertrophy. - Holter monitor: Monitors heart activity over 24-48 hours to detect arrhythmias. - Genetic testing: May be recommended to identify inherited causes or for family screening.
Treatment Protocols: Management of other hypertrophic cardiomyopathy focuses on controlling symptoms and preventing complications. Treatment options include: - Lifestyle modifications: Avoiding strenuous activities that could precipitate symptoms. - Medications: - Beta-blockers: Reduce heart rate and workload. - Calcium channel blockers: Help relax heart muscle and improve symptoms. - Implantable devices: - Cardioverter-defibrillators (ICDs): Used in patients at risk of dangerous arrhythmias. - Regular follow-up: Monitoring heart function and rhythm over time. - Surgical options: Rarely needed for nonobstructive forms, but procedures like septal myectomy are more common in obstructive hypertrophic cardiomyopathy. It’s important to remember that treatment plans are personalized, and medical decisions are made by healthcare providers based on individual patient conditions.
Clinical Advice & FAQs
Billing Guidance
Is I42.2 a billable ICD-10 code?
Yes, I42.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I42.2?
Clinical documentation must specify the nature of Other hypertrophic cardiomyopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference